Connect with us

Health

Green tea compound may prevents death from heart attack

Gorkha Post

Published

on

Green tea compound could hold the key to preventing thousands of deaths each year caused by strokes and heart disease, a new study, conducted by the British Heart Foundation, has claimed.

Researchers had been researching epigallocatechin-3-gallate (EGCG), a compound found in green tea, for its ability to reduce amyloid plaques in the brains of Alzheimer’s disease patients.

Researchers from Lancaster University and the University of Leeds discovered that EGCG compound found in green tea, currently being studied for its ability to reduce amyloid plaques in the brain in Alzheimer’s disease, also breaks up and dissolves potentially dangerous protein plaques found in blood vessels.

ALSO READ :  Man beats wife to death in Siraha

“The health benefits of green tea have been widely promoted and it has been known for some time that EGCG can alter the structures of amyloid plaques associated with Alzheimer’s disease. Our results show that this intriguing compound might also be effective against the types of plaques which can cause heart attacks and strokes,” says researcher David Middleton.

The study is published in the Journal of Biological Chemistry.

The team is now working on finding ways to introduce effective amounts of EGCG into the bloodstream without it being necessary to drink large and potentially harmful quantities of green tea.

Continue Reading

Health

Single blood test might be enough to diagnose diabetes

Gorkha Post

Published

on

A new study report has suggested that it may be possible to diagnose type 2 diabetes by measuring fasting blood glucose and hemoglobin A1c (HbA1c) using the same blood sample without requiring a patient to come back for a second visit and saving patients time and health care cost.

The findings, from the prospective Atherosclerosis Risk in Communities (ARIC) study, were published online June 19 in Annals of Internal Medicine by Elizabeth Selvin, PhD, of Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, and colleagues.

Until now, it’s recommended that a blood test focused on elevated fasting levels of blood sugar (glucose) or a blood component called glycated hemoglobin (HbA1c) be confirmed with a second blood test at a follow-up visit which takes time and money and could still result in missed diagnoses, said a team from the Johns Hopkins Bloomberg School of Public Health in Baltimore.

In the new study, researchers led by Hopkins epidemiologist Elizabeth Selvin looked at data on more than 13,000 people in a long-running US heart disease study. The study began in the 1980s, and along the way has recorded valuable data from participants, including diabetes test data.

ALSO READ :  Drinking more water doesn't slow kidney disease in chronic kidney patients

The team analyzed that data, and reported that a positive result for glucose and HbA1c from just a single blood sample can confirm type 2 diabetes.

” This could change care potentially allowing a major simplification of current clinical practice guidelines,” Selvin said in a university news release.

“Doctors are already doing these [glucose and HbA1c] tests together — if a patient is obese, for example, and has other risk factors for diabetes, the physician is likely to order tests for both glucose and HbA1c from a single blood sample.

“It’s just that the guidelines don’t clearly let you use the tests from that one blood sample to make the initial diabetes diagnosis,” she explained.

“I’m hoping that these results will lead to a change in the clinical guidelines when they are revised in early 2019, which could make identifying diabetes a lot more efficient in many cases,” Selvin said.

Diabetes experts welcomed the findings.

With Agency Inputs

Continue Reading

TOP PICKS